Expanded Access Program (EAP) in Oman
How the expanded access program (eap) pathway operates in Oman.
About Expanded Access Program (EAP)
Structured programs offering access to investigational drugs outside of clinical trials.
How Expanded Access Program (EAP) works in Oman
Oman's MoH operates a personal-import pathway; volumes are smaller but the pathway is functional for rare-disease and specialty needs.
Patients in Oman seeking access under Expanded Access Program (EAP) typically follow this flow: a licensed physician in Oman issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Oman
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.